Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
My Bing
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
Trending on Bing
Mexico elects 1st woman pres
Cowboys Hall of Famer dies
Calls on Supreme Court
Announces farewell tour
2 suspects in custody
Murder charges dropped
To attend UKR peace summit
CA braces for extreme heat
Says Trump should be jailed
S9 gets Netflix premiere date
Clips power line, several hurt
4-year, $140M contract
Testifies on COVID origins
US factory activity slips
Launches new AI chips
Jury selection begins in trial
Airlines raise profit outlook
GameStop shares surge
Trial ‘very hard’ on wife
In-person voting behind bars
Late matches are 'not healthy'
Sells 10% stake for $1.05B
WI prison warden quits
157th NHRA victory
Detroit train station restored
Revised Skydance offer
Pittsburgh shooting kills 2
Pres Smith on AI deepfakes
Hikes prices of premium plans
World Athletics new event
Blue Lagoon reopens
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Moderna, RSV
FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product
The decision is a win for Moderna, which needs another revenue source amid plunging demand for its Covid vaccine, its only commercially available product.
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Moderna MRNA announced that the FDA approved its mRNA-based RSV vaccine mRNA-1345 to prevent RSV-associated lower respiratory tract disease (RSV-LRTD) in older adults aged 60 years and above. The vaccine will be marketed under the trade name mResvia.
FDA approves Moderna's RSV vaccine, its second marketed product
The Food and Drug Administration approved Moderna's RSV vaccine to prevent lower respiratory tract disease in adults aged 60 or older
19d
Moderna Q1: A Promising Pipeline Is Undervalued
Moderna reported better-than-expected 1Q24 revenue of $167 million and its pipeline looks promising. Read my earnings ...
18d
US FDA approves expanded use of Bristol's cancer cell therapy
The U.S. Food and Drug Administration on Wednesday approved the expanded use of Bristol Myers Squibb's cancer cell therapy Breyanzi to include the treatment of adults with a type of blood cancer that ...
2d
News updates from May 31: Biden says Israel has offered new ceasefire proposal; S&P downgrades France’s credit rating
Donald Trump said he will appeal against the guilty verdict against him in the “hush money” trial and maintained his ...
3d
Wall Street Breakfast: A Conviction
This article discusses Donald Trump convicted on 34 charges of falsifying business records, the upcoming PCE data, Boeing's ...
4d
Guillain-Barre syndrome 'more common than expected' with RSV vaccine in older people, CDC reiterates
Reports of a rare nervous system disorder are "more common than expected" in older U.S. adults who got the new RSV vaccines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback